ATE178357T1 - Nachweismethoden für c-raf-1-genes.5 - Google Patents
Nachweismethoden für c-raf-1-genes.5Info
- Publication number
- ATE178357T1 ATE178357T1 AT92920292T AT92920292T ATE178357T1 AT E178357 T1 ATE178357 T1 AT E178357T1 AT 92920292 T AT92920292 T AT 92920292T AT 92920292 T AT92920292 T AT 92920292T AT E178357 T1 ATE178357 T1 AT E178357T1
- Authority
- AT
- Austria
- Prior art keywords
- raf
- genes
- detection methods
- cancer
- determining
- Prior art date
Links
- 238000001514 detection method Methods 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 201000011510 cancer Diseases 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 238000004393 prognosis Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75973891A | 1991-09-16 | 1991-09-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE178357T1 true ATE178357T1 (de) | 1999-04-15 |
Family
ID=25056776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92920292T ATE178357T1 (de) | 1991-09-16 | 1992-09-16 | Nachweismethoden für c-raf-1-genes.5 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0612353B1 (de) |
JP (1) | JPH08506000A (de) |
AT (1) | ATE178357T1 (de) |
AU (1) | AU666336B2 (de) |
CA (1) | CA2118724C (de) |
DE (1) | DE69228824T2 (de) |
WO (1) | WO1993006248A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5582995A (en) * | 1993-06-11 | 1996-12-10 | The General Hospital Corporation | Methods of screening for compounds which inhibit the direct binding of Ras to Raf |
US6358932B1 (en) | 1994-05-31 | 2002-03-19 | Isis Pharmaceticals, Inc. | Antisense oligonucleotide inhibition of raf gene expression |
US5563255A (en) * | 1994-05-31 | 1996-10-08 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of raf gene expression |
US5656612A (en) * | 1994-05-31 | 1997-08-12 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of raf gene expression |
US5981731A (en) * | 1994-05-31 | 1999-11-09 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of B-raf gene expression |
US5744362A (en) * | 1994-05-31 | 1998-04-28 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of raf gene expression |
US6391636B1 (en) | 1994-05-31 | 2002-05-21 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of raf gene expression |
US6090626A (en) * | 1994-05-31 | 2000-07-18 | Isis Pharmaceuticals Inc. | Antisense oligonucleotide modulation of raf gene expression |
US6410518B1 (en) | 1994-05-31 | 2002-06-25 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide inhibition of raf gene expression |
KR100211178B1 (ko) * | 1994-05-31 | 1999-07-15 | 파샬 비. 린네 | 라프유전자 발현의 안티센스 올리고뉴클레오티드 조절 |
US7262173B2 (en) | 1997-03-21 | 2007-08-28 | Georgetown University | Chemosensitizing with liposomes containing oligonucleotides |
DE10020138A1 (de) * | 2000-04-14 | 2001-10-31 | Ulf R Rapp | Nukleinsäure codierend für zumindest eine raf Teilsequenz mit einer MEKK1 Bindungsstelle |
WO2002081641A2 (en) | 2001-04-06 | 2002-10-17 | Georgetown University | Gene scc-112 and diagnostic and therapeutic uses thereof |
AU2002303261A1 (en) | 2001-04-06 | 2002-10-21 | Georgetown University | Gene brcc2 and diagnostic and therapeutic uses thereof |
WO2002081642A2 (en) | 2001-04-06 | 2002-10-17 | Georgetown University | Gene brcc-3 and diagnostic and therapeutic uses thereof |
US7244565B2 (en) | 2002-04-10 | 2007-07-17 | Georgetown University | Gene shinc-3 and diagnostic and therapeutic uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0458831A1 (de) * | 1989-02-16 | 1991-12-04 | BALAZS, Viktor, Dr. Dr. med. | Malignitätstest (krebs-test) mit verwendung von der polymerasekettenreaktion |
AU630001B2 (en) * | 1989-10-02 | 1992-10-15 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | A sensitive method for measurement of chimeric transcripts of dna containing translocations |
JP2552047B2 (ja) * | 1990-01-26 | 1996-11-06 | ワシントン リサーチ ファウンデーション | 悪性腫瘍の検査方法 |
CA2075053A1 (en) * | 1990-02-07 | 1991-08-08 | Francis P. Mccormick | Detection of point mutations in genes encoding gtp binding proteins |
WO1991019006A1 (en) * | 1990-06-01 | 1991-12-12 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | MONOCLONAL ANTIBODIES FOR IDENTIFICATION AND PREPARATION OF raf-1 ONCOPROTEIN |
-
1992
- 1992-09-16 WO PCT/US1992/007817 patent/WO1993006248A1/en active IP Right Grant
- 1992-09-16 JP JP5506186A patent/JPH08506000A/ja active Pending
- 1992-09-16 CA CA002118724A patent/CA2118724C/en not_active Expired - Fee Related
- 1992-09-16 AT AT92920292T patent/ATE178357T1/de not_active IP Right Cessation
- 1992-09-16 AU AU26589/92A patent/AU666336B2/en not_active Ceased
- 1992-09-16 DE DE69228824T patent/DE69228824T2/de not_active Expired - Fee Related
- 1992-09-16 EP EP92920292A patent/EP0612353B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0612353A1 (de) | 1994-08-31 |
AU666336B2 (en) | 1996-02-08 |
AU2658992A (en) | 1993-04-27 |
WO1993006248A1 (en) | 1993-04-01 |
DE69228824T2 (de) | 1999-12-09 |
EP0612353B1 (de) | 1999-03-31 |
JPH08506000A (ja) | 1996-07-02 |
DE69228824D1 (de) | 1999-05-06 |
CA2118724A1 (en) | 1993-04-01 |
CA2118724C (en) | 2002-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE178357T1 (de) | Nachweismethoden für c-raf-1-genes.5 | |
ATE123301T1 (de) | Gentechnologisch-hergestellte aprotinin-homologe. | |
DE69842208D1 (de) | Vorrichtung für eine isolierte Beckenperfusion | |
EP1099102A4 (de) | Spurendetektion von analyten mit hilfe artifizieller olfaktometrie | |
NO873753D0 (no) | Periodisk biologisk luftbehandlingsprosess og system for denne. | |
DE69737684D1 (de) | Präzise wirksamkeitsbestimmungsmethode für wirkstoffe einschliesslich chemotherapeutika | |
IL142824A0 (en) | Lipoic acid derivatives and their use in treatment of disease | |
DE69111664D1 (de) | Blutpumpe und Apparat für die extracorporale Blutzirkulation. | |
ATE181422T1 (de) | Verfahren zur diagnose von praeklampsie | |
IT8124138A0 (it) | Procedimento e apparecchio per determinare quantitativamente il livello di emoglobina in campioni biologici. | |
DE69019886T2 (de) | Katheter und Instrumentarium zur extrakorporalen Zirkulation. | |
ATE395433T1 (de) | Screeningverfahren für geeignete wirkstoffe | |
FI933291A0 (fi) | Foerfarande foer paovisning av anti-rna-antikroppar | |
FI924363A0 (fi) | Foerfarande foer behandling och/eller diagnostisering av mjukvaevnadstumoerer. | |
DE3874638D1 (de) | Behandlungsapparat und -verfahren. | |
ZA92264B (en) | Prescreening of prostate cancer by serum prostatic specific antigen. | |
DK1313850T3 (da) | Nucleinsyre og tilsvarende protein med navnet 85PB3 anvendelige til behandling og påvisning af cancer | |
DE3873848T2 (de) | Behandlungsapparat und -verfahren. | |
SU640002A1 (ru) | Скважина | |
DE69637325D1 (de) | Methode für die behandlung einer hepatitisvirusinfektion | |
ATE520031T1 (de) | Ibc-1 (invasive breast cancer-1), ein bei brustkrebs amplifiziertes mutmassliches onkogen | |
IL113346A0 (en) | Method to identify immunocompromised patients at high risk for cryptococcosis | |
UA31956A (uk) | Спосіб оцінки ефективності лікування хворих на псоріаз і псоріатичний артрит | |
IT1276615B1 (it) | Metodo per la rivelazione di catecolamine durante il ritmo circadiano, uso di detto metodo per la diagnosi e la terapia di malattie nervose | |
NO882114D0 (no) | Fremgangsmaate og innretning for mammogafisk undersoekelse. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |